Literature DB >> 8576818

Endomysial antibodies as unreliable markers for slight dietary transgressions in adolescents with celiac disease.

R Troncone1, M Mayer, F Spagnuolo, L Maiuri, L Greco.   

Abstract

Adolescents with celiac disease often fail to adhere to a strict gluten-free diet. The value of endomysial antibodies in assessing the dietary compliance of such adolescents has been assessed in 23 patients divided into four groups according to their daily gluten intake. Serum endomysial antibodies were absent in all subjects on a gluten-free diet and consistently present in those ingesting > 2 g/day of gluten. Only one of six and three of six teenagers with celiac disease with an intake of < 0.5 and 0.5-2 g/day, respectively, had endomysial antibodies in their serum, despite the presence in three of six and five of six of significant changes in the mucosal architecture, as shown by computerized morphometry of jejunal biopsies. In conclusion, endomysial antibodies cannot be considered a valid marker for slight dietary transgressions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8576818     DOI: 10.1097/00005176-199507000-00012

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  17 in total

1.  IgG(1) antiendomysium and IgG antitissue transglutaminase (anti-tTG) antibodies in coeliac patients with selective IgA deficiency. Working Groups on Celiac Disease of SIGEP and Club del Tenue.

Authors:  F Cataldo; D Lio; V Marino; A Picarelli; A Ventura; G R Corazza
Journal:  Gut       Date:  2000-09       Impact factor: 23.059

Review 2.  Endomysial antibody in the diagnosis and management of coeliac disease.

Authors:  M W James; B B Scott
Journal:  Postgrad Med J       Date:  2000-08       Impact factor: 2.401

Review 3.  Refractory sprue.

Authors:  Andrea N Culliford; Peter H R Green
Journal:  Curr Gastroenterol Rep       Date:  2003-10

4.  Nuclear fluorescence serum reactivity on monkey oesophagus: a new antibody for the follow-up of coeliac disease?

Authors:  A Picarelli; L Sabbatella; M Di Tola; M Silano; A Nicolussi; S D'Inzeo; A Coppa
Journal:  Clin Exp Immunol       Date:  2010-09       Impact factor: 4.330

5.  Clinical application of immunological markers as monitoring tests in celiac disease.

Authors:  M Fotoulaki; S Nousia-Arvanitakis; P Augoustidou-Savvopoulou; F Kanakoudi-Tsakalides; T Zaramboukas; J Vlachonikolis
Journal:  Dig Dis Sci       Date:  1999-10       Impact factor: 3.199

6.  Effectiveness of antigliadin antibodies as a screening test for celiac disease in children.

Authors:  L J Chartrand; J Agulnik; T Vanounou; P A Russo; P Baehler; E G Seidman
Journal:  CMAJ       Date:  1997-09-01       Impact factor: 8.262

Review 7.  Tests for Serum Transglutaminase and Endomysial Antibodies Do Not Detect Most Patients With Celiac Disease and Persistent Villous Atrophy on Gluten-free Diets: a Meta-analysis.

Authors:  Jocelyn A Silvester; Satya Kurada; Andrea Szwajcer; Ciarán P Kelly; Daniel A Leffler; Donald R Duerksen
Journal:  Gastroenterology       Date:  2017-05-22       Impact factor: 22.682

Review 8.  Treatment regimen adherence in pediatric gastroenterology.

Authors:  Kevin A Hommel; Laura M Mackner; Lee A Denson; Wallace V Crandall
Journal:  J Pediatr Gastroenterol Nutr       Date:  2008-11       Impact factor: 2.839

9.  Serum I-FABP Detects Gluten Responsiveness in Adult Celiac Disease Patients on a Short-Term Gluten Challenge.

Authors:  Marlou P M Adriaanse; Daniel A Leffler; Ciaran P Kelly; Detlef Schuppan; Robert M Najarian; Jeffrey D Goldsmith; Wim A Buurman; Anita C E Vreugdenhil
Journal:  Am J Gastroenterol       Date:  2016-05-17       Impact factor: 10.864

10.  Practical considerations for the identification and follow-up of children with celiac disease.

Authors:  Martha H Dirks
Journal:  Paediatr Child Health       Date:  2004-12       Impact factor: 2.253

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.